Clinical trial

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

NCT06984510

Study summary

ClinicalTrials.gov

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Observational Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-04-01

PhaseN/A

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Metabolic Dysfunction-Associated Steatotic Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Biological Ageunresolved

Interventions

ObservationalOTHER

Sponsors & collaborators

Ningbo No. 1 Hospitallead sponsor

Mapped research locations

NingboZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06984510 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.